Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Lam H, Saoud C, Shi Q, Wong KS, Cibas ES, Rooper LM, et al. Degenerative atypia in benign thyroid nodules: a potential diagnostic pitfall on fine-needle aspiration. J Am Soc Cytopathol. 2023;12(5):341-350.

Saoud C, Illei PB, Siddiqui MT, Ali SZ. Cytopathology of rare gastric mesenchymal neoplasms: A series of 25 cases and review of literature. Cytopathology. 2023;34(1):15-27.

Thomas JL, Tee MW, Harp J, Magro C. Azathioprine hypersensitivity syndrome manifesting as subcutaneous Sweet syndrome and acute pancreatitis. J Cutan Pathol. 2023;50(2):127-130.

Pallasaho S, Gondane A, Kuivalainen A, Girmay S, Moestue S, Loda M, et al. Castration-resistant prostate cancer cells are dependent on the high activity of CDK7. J Cancer Res Clin Oncol. 2023;149(8):5255-5263.

Mukhopadhyay C, Zhou P. Role(s) of G3BPs in Human Pathogenesis. J Pharmacol Exp Ther. 2023;387(1):100-110.

Sud K, Narula N, Aikawa E, Arbustini E, Pibarot P, Merlini G, et al. Author Correction: The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis. Nat Rev Cardiol. 2023;20(6):429.

Tong J, Aksenov S, Siegel BM, Wei L, Rodgers WH. A Rare Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Occurred in Postchemotherapy of Breast Cancer. Case Rep Hematol. 2023;2023:7573037.

Thejeel B, Geannette CS, Roytman M, Pisapia DJ, Chazen JL, Jawetz ST. Patterns of Intrathecal Ossification in Arachnoiditis Ossificans: A Retrospective Case Series. AJNR Am J Neuroradiol. 2023;44(2):228-234.

Hahn NM, O'Donnell MA, Efstathiou JA, Zahurak M, Rosner GL, Smith J, et al. A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study. Eur Urol. 2023;83(6):486-494.

Marinoff AE, Spurr LF, Fong C, Li YY, Forrest SJ, Ward A, et al. Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma. JCO Precis Oncol. 2023;7:e2200334.